<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-23164" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Hyperchloremic Acidosis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sharma</surname>
            <given-names>Sandeep</given-names>
          </name>
          <aff>Mery Fitzgerald Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hashmi</surname>
            <given-names>Muhammad F.</given-names>
          </name>
          <aff>National Health Service</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Aggarwal</surname>
            <given-names>Sandeep</given-names>
          </name>
          <aff>Drexel University College of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sandeep Sharma declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Hashmi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sandeep Aggarwal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-23164.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Hyperchloremic metabolic acidosis is a pathological state that results from bicarbonate loss, rather than acid production or retention. Bicarbonate loss leading to hyperchloremic metabolic acidosis occurs in a variety of ways: gastrointestinal (GI) causes, renal causes, and exogenous causes. GI loss of bicarbonate occurs through severe diarrhea, pancreatic fistula, nasojejunal tube suctioning from the duodenum, and chronic laxative use. This activity reviews the causes and presentation of hyperchloremic metabolic acidosis and highlights the role of the interprofessional team in evaluating and improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the evaluation of a patient with hyperchloremic metabolic acidosis.</p></list-item><list-item><p>Review the causes of hyperchloremic metabolic acidosis.</p></list-item><list-item><p>Summarize the treatment of hyperchloremic metabolic acidosis.</p></list-item><list-item><p>Explain modalities to improve care coordination among interprofessional team members in order to improve outcomes for patients affected by hyperchloremic metabolic acidosis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23164&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23164">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-23164.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Normal physiological pH is 7.35 to 7.45. A decline in pH below this range is called acidosis, an increase in this range is known as alkalosis. Hyperchloremic acidosis is a disease state where acidosis (pH less than 7.35) develops with an increase in ionic chloride.&#x000a0;Understanding the physiological pH buffering system is important. The major pH buffer system in the human body is the bicarbonate/carbon dioxide (HCO3/CO2) chemical equilibrium system.<xref ref-type="bibr" rid="article-23164.r1">[1]</xref><xref ref-type="bibr" rid="article-23164.r2">[2]</xref><xref ref-type="bibr" rid="article-23164.r3">[3]</xref></p>
        <p>Where:</p>
        <list list-type="bullet">
          <list-item>
            <p>H + HCO3 &#x0003c;-- --&#x0003e; H2CO3 &#x0003c;-- --&#x0003e; CO2 + H2O</p>
          </list-item>
        </list>
        <p>HCO3 acts as an alkalotic substance, while&#x000a0;CO2 functions as an acid. Therefore, an increase in HCO3 or a decrease in CO2 will make blood more alkalotic. In contrast, a decrease in HCO3 or an increase in CO2 will shift the acid-base balance towards acidic. The pulmonary system regulates CO2 levels through respiration; However, the HCO3 levels are regulated through the renal system with the help of reabsorption. Therefore, hyperchloremic metabolic acidosis is a decline in HCO3 levels in the blood.</p>
        <p>
<bold>Related Testing</bold>
</p>
        <p>When a metabolic acidosis is suspected, it is crucial to calculate the anion gap. This is defined as:</p>
        <list list-type="bullet">
          <list-item>
            <p>Serum anion gap = (Na) - [(HCO3 + Cl)]</p>
          </list-item>
        </list>
        <p>Where Na&#x000a0;is plasma sodium concentration, HCO3 is plasma bicarbonate concentration, and Cl represents plasma chloride concentration.</p>
        <p>The anion gap is an estimation to determine the quantity of ionically active components within the blood that are not routinely measured. Since there are always such components that are not directly measured, we expect this value never to be equal to zero. The primary unmeasured physiologically active ion is albumen. A normal serum anion gap is measured to be 8 to 16 mEq/L. An increase in the anion gap is associated with renal failure, ketoacidosis, lactic acidosis, and ingestion of toxins, whereas a lowered bicarbonate concentration characterizes a normal anion gap acidosis.</p>
      </sec>
      <sec id="article-23164.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The human body is very good at remaining balanced&#x000a0;ionically&#x000a0;under most scenarios. As a result, with loss of bicarbonate (the negatively charged ion), the negatively charged chloride (Cl) ion is displaced to the extracellular space.&#x000a0;This leads to a narrow anion gap, an electrically neutral state without correcting the pathology that induced the acidosis. Likewise, increased Cl may displace bicarbonate intracellularly. To determine the exact etiology of a narrow anion gap, hyperchloremic acidosis requires another test, the urine anion gap. The urine anion gap is calculated as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Urine anion gap = (Na + K) - Cl</p>
          </list-item>
        </list>
        <p>Where Na is urine sodium, K is urine potassium, and Cl is urine chloride. The urine anion gap provides an estimate of urinary ammonium (NH4) excretion. The normal renal response to metabolic acidosis is to increase acidic NH4&#x000a0;excretion renally. Therefore, a positive urine anion gap between 20 and 90&#x000a0;mEq/L&#x000a0;is indicative of low or normal NH4 excretion, seen in renal causes, such as distal renal tubular acidosis. A negative urine anion gap between -20 and -50&#x000a0;mEq/L&#x000a0;is indicative of increased NH4 excretion. This occurs in patients with metabolic acidosis generated by extrarenal causes, such as profuse watery diarrhea. A urine anion gap approaching 0 is indeterminate.<xref ref-type="bibr" rid="article-23164.r4">[4]</xref></p>
      </sec>
      <sec id="article-23164.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The prevalence of hyperchloremic acidosis is unknown. The exact frequency and distribution of disease are dependent upon the etiology. Likewise, the morbidity and mortality rates are dependent on the etiology of the disease.</p>
      </sec>
      <sec id="article-23164.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Hyperchloremic metabolic acidosis is a pathological state that results from bicarbonate loss, rather than acid production or retention. Bicarbonate loss leading to hyperchloremic metabolic acidosis occurs in a variety of ways: gastrointestinal (GI) causes, renal causes, and exogenous causes. GI&#x000a0;loss of bicarbonate occurs through severe diarrhea, pancreatic fistula, nasojejunal tube suctioning from the duodenum, and chronic laxative use. Renal sources of hyperchloremic acidosis include proximal renal tubular acidosis, distal renal tubular acidosis, and long-term use of carbonic anhydrase inhibitors. Exogenous causes include the ingestion of acids such as ammonium chloride and hydrochloric acid and volume resuscitation with 0.9% saline.<xref ref-type="bibr" rid="article-23164.r5">[5]</xref><xref ref-type="bibr" rid="article-23164.r6">[6]</xref><xref ref-type="bibr" rid="article-23164.r7">[7]</xref><xref ref-type="bibr" rid="article-23164.r8">[8]</xref><xref ref-type="bibr" rid="article-23164.r9">[9]</xref></p>
        <p>
<bold>Gastrointestinal Causes</bold>
</p>
        <p>Normally, there is a degree of bicarbonate secreted into the intestinal lumen to allow for neutralization of the acidic environment of food from gastric emptying. Over the distance of the small intestines, this bicarbonate is reabsorbed as bile. However, in pathologies with profuse watery diarrhea, bicarbonate within the intestines is lost through the stool due to increased motility of the gut. This leads to further secretion of bicarbonate from the pancreas and intestinal mucosa, leading to net acidification of the blood from bicarbonate loss. Likewise, pancreatic fistula leads to excessive bicarbonate secretion from the pancreas into the intestines. This excess bicarbonate is ultimately lost in stools. Nasojejunal suctioning removes bicarbonate from the duodenal or jejunal space via direct suctioning of the luminal contents. The overarching theme with these pathologies is the loss of bicarbonate from the gastrointestinal spaces, which leads to an acidotic state in the blood via unopposed hydrogen in the buffering system as above.</p>
        <p>
<bold>Renal Causes</bold>
</p>
        <p>Distal renal tubular acidosis (type 1) is a failure of the distal nephron to secrete hydrogen appropriately into the urine. This results in alkalotic urine and acidosis of the blood.&#x000a0;Failure to secrete hydrogen directly correlates with the NH4 levels in urine and is able to be deduced via a positive urine anion gap as above. Proximal renal tubular acidosis (type 2) is a pathology where bicarbonate is failed to be reabsorbed appropriately. This leads to the loss of bicarbonate in the urine. The net result is acidosis of blood and alkalotic urine. Both types of renal tubular acidosis are associated with hypokalemia. Carbonic anhydrase inhibitors such as acetazolamide create a medically induced type 2 proximal renal tubular acidosis scenario by inhibiting bicarbonate reabsorption in the proximal nephron.</p>
        <p>
<bold>Exogenous Causes</bold>
</p>
        <p>Many of the exogenous causes of hyperchloremic acidosis are logical evaluations. When substances such as ammonium chloride and hydrochloric acid are&#x000a0;supplemented into the body, they react with bicarbonate in an attempt to buffer the pH. However, this will deplete bicarbonate stores leading to an acidotic state.&#x000a0;Large volume resuscitation with normal saline leads to an overload of chloride ions into the blood. As stated previously, chloride and bicarbonate work together to maintain an ionic balance of the cellular space. Hyperchlorhydria forces bicarbonate to move intracellularly to maintain ionic equilibrium, thus reducing the available bicarbonate for the pH buffering system leading to net acidosis.</p>
      </sec>
      <sec id="article-23164.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with hyperchloremic acidosis have no effects due to the hyperchloremia necessarily. However, acidosis can have many poor health effects. A headache, lack of energy, nausea, and vomiting are common complaints, however as acidosis worsens, stupor, coma, myocardial instability, or arrest may occur. It is expected to see an increase in respiratory rate as the body attempts to decrease carbon dioxide in compensation; however, in long-standing disease, this may lead to muscle fatigue and respiratory failure.</p>
        <p>A physical exam may show altered mental status, tachycardia, tachypnea, accessory muscle use with respiration, neurological deficits, muscular weakness, cardiac arrhythmias, cardiac murmurs, respiratory wheezing, rales, or rhonchi.</p>
      </sec>
      <sec id="article-23164.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>As with any illness, a detailed history and physical exam is the most important initial step in evaluation. Hyperchloremic acidosis due to gastrointestinal bicarbonate loss or medication usage is apparent easily. A complete blood count (CBC) to evaluate for an infectious cause with elevated white blood count and fluid body status with hemoglobin and hematocrit values is useful. A complete metabolic panel is important with attention to sodium, potassium, and chloride levels as these can be used to calculate the anion gap value. Arterial blood gas measurement is needed to determine pH status and to identify that the acidosis is metabolic in origin. The urinary anion gap is an essential measurement in hyperchloremic acidosis to establish the urine ammonium excretion status, as discussed above. Distal renal tubular acidosis will have urinary pH greater than 5.3 and a positive urinary anion gap. In proximal renal tubular acidosis, urinary pH is usually less than 5.3, and the urinary anion gap is variable.<xref ref-type="bibr" rid="article-23164.r10">[10]</xref></p>
      </sec>
      <sec id="article-23164.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>In every case of hyperchloremic acidosis, the primary treatment is aimed at identifying and treating the inciting event of pathology. If respiratory fatigue and failure occur, these patients will need to be intubated and placed on mechanical ventilation. Hyperventilation of the patient on ventilator control can help reduce the acid load. In gastrointestinal causes, it is essential to administer intravenous (IV) normal saline to maintain fluid load as patients will easily dehydrate from diarrhea or suctioning of the intestines. Additionally, electrolytes need to be monitored and replenished as applicable. Of specific importance is the potassium level. The acidosis is moderated by supplementing bicarbonate into the saline fluids until the underlying pathology is repaired. In proximal renal tubular acidosis, large quantities of bicarbonate, vitamin D, and potassium administration are required. The usual dose of bicarbonate is 5-15 mE/kg/day. In hypokalemic distal renal tubular acidosis long-term alkali administration to counterbalance bicarbonaturia and endogenous acid production. Potassium supplements are also needed. In hyperkalemic distal renal tubular acidosis, obstructive uropathy must be identified. If fluid overload is a concern, diuretics with supplemental potassium may be administered for some effect. If the acidosis is resistant to therapy, it may be necessary to utilize dialysis therapy.<xref ref-type="bibr" rid="article-23164.r11">[11]</xref><xref ref-type="bibr" rid="article-23164.r12">[12]</xref><xref ref-type="bibr" rid="article-23164.r13">[13]</xref><xref ref-type="bibr" rid="article-23164.r14">[14]</xref></p>
        <p>As always, a variety of medications are known to induce hyperchloremic acidosis and should be avoided or used with caution. Gastrointestinal bicarbonate loss is known to&#x000a0;occur with calcium chloride, magnesium sulfate, and cholestyramine use. Proximal renal tubular acidosis is associated with streptozotocin, lead, mercury, arginine, valproic acid, gentamicin, ifosfamide, and outdated tetracycline usage. Distal renal tubular acidosis is associated with amphotericin B, toluene, nonsteroidal anti-inflammatory drugs, and lithium use.<xref ref-type="bibr" rid="article-23164.r15">[15]</xref></p>
      </sec>
      <sec id="article-23164.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Conditions that may present with features similar to hyperchloremic acidosis include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Non-anion gap metabolic acidosis</p>
          </list-item>
          <list-item>
            <p>Vitamin D deficiency</p>
          </list-item>
          <list-item>
            <p>Renal tubular acidosis</p>
          </list-item>
          <list-item>
            <p>Vitamin D resistance</p>
          </list-item>
          <list-item>
            <p>Chronic diarrhea or other extrarenal loss of bicarbonate</p>
          </list-item>
          <list-item>
            <p>Monoclonal gammopathy and myeloma</p>
          </list-item>
          <list-item>
            <p>Secondary hyperparathyroidism</p>
          </list-item>
          <list-item>
            <p>Chronic hypocalcemia</p>
          </list-item>
          <list-item>
            <p>Lowe syndrome</p>
          </list-item>
          <list-item>
            <p>Sickle cell disease</p>
          </list-item>
          <list-item>
            <p>Obstructive uropathy</p>
          </list-item>
          <list-item>
            <p>Fabry disease</p>
          </list-item>
          <list-item>
            <p>Metachromatic leukodystrophy</p>
          </list-item>
          <list-item>
            <p>Methylmalonic acidemia</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23164.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of hypochloremic metabolic acidosis depends on the underlying cause of the condition. When the underlying cause is well managed, the prognosis is usually very good. Hyperchloremic metabolic acidosis can be detrimental in old age and those who already have a cardiopulmonary compromise.</p>
      </sec>
      <sec id="article-23164.s11" sec-type="Complications">
        <title>Complications</title>
        <p>If hyperchloremic acidosis is not corrected, acidemia can cause arrhythmias which can prove fatal and increase mortality. pH less than 7.2 can impair myocardial contraction and increase the risk of ventricular fibrillation and heart failure. Tachypnea results in compensation of acidosis can cause respiratory muscle fatigue and if not corrected promptly can lead to respiratory arrest.</p>
      </sec>
      <sec id="article-23164.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>The management of hyperchloremic metbolic acidosis depends on the underlying cause and is teamwork. Following specialities are involved in the management:</p>
        <list list-type="bullet">
          <list-item>
            <p>Nephrologist</p>
          </list-item>
          <list-item>
            <p>Internist</p>
          </list-item>
          <list-item>
            <p>Intensivist</p>
          </list-item>
          <list-item>
            <p>Endocrinologist</p>
          </list-item>
          <list-item>
            <p>Cardiologist</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23164.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>A variety of drugs can aggravate or cause hyperchloremic metabolic acidosis. Such drugs should be identified and immediately stopped. The patient should be advised to take a potassium-rich or depleted diet depending on the serum potassium levels and water intake should also be guided by the volume status of the patient.</p>
      </sec>
      <sec id="article-23164.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management of hyperchloremic acidosis is with an interprofessional team that consists of a nephrologist, internist, endocrinologist, cardiologist, and a pulmonologist. The acidosis can result in many symptoms and even lead to cardiac arrest and respiratory failure. The key is to manage the primary condition causing the hyperchloremic acidosis. Patients with respiratory and cardiac symptoms may need close monitoring, and the acidosis may have to be reversed with bicarbonate. It is vital to rule out any medication causing the acidosis. For most patients, the prognosis is okay as long as the primary condition is managed. Failure to manage the primary condition can lead to high morbidity and mortality.<xref ref-type="bibr" rid="article-23164.r16">[16]</xref><xref ref-type="bibr" rid="article-23164.r17">[17]</xref> (Level V)</p>
      </sec>
      <sec id="article-23164.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23164&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23164">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/hormones-and-body-chemistry/hyperchloremic-acidosis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=23164">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/23164/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=23164">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-23164.s16">
        <title>References</title>
        <ref id="article-23164.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farrokh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Suarez</surname>
                <given-names>JI</given-names>
              </name>
            </person-group>
            <article-title>Fluids and hyperosmolar agents in neurocritical care: an update.</article-title>
            <source>Curr Opin Crit Care</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>105</fpage>
            <page-range>105-109</page-range>
            <pub-id pub-id-type="pmid">30676327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23164.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giordano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ciarambino</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Castellino</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Malatino</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Signoriello</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Paolisso</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Adinolfi</surname>
                <given-names>LE</given-names>
              </name>
            </person-group>
            <article-title>Correlation of Hyperchloremic Metabolic Acidosis and Renal Function in Critically ill Patients of Emergency Department: an Observational Study.</article-title>
            <source>Emerg (Tehran)</source>
            <year>2018</year>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>e52</fpage>
            <pub-id pub-id-type="pmid">30584568</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23164.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weiss</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Paugam-Burtz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jaber</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Shock Etiologies and Fluid Management in Liver Failure.</article-title>
            <source>Semin Respir Crit Care Med</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>39</volume>
            <issue>5</issue>
            <fpage>538</fpage>
            <page-range>538-545</page-range>
            <pub-id pub-id-type="pmid">30485884</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23164.r4">
          <label>4</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Hopkins</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sanvictores</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <chapter-title>Physiology, Acid Base Balance</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2022</year>
            <month>9</month>
            <day>12</day>
            <pub-id pub-id-type="pmid">29939584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23164.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alexander</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Bitzan</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Renal Tubular Acidosis.</article-title>
            <source>Pediatr Clin North Am</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>66</volume>
            <issue>1</issue>
            <fpage>135</fpage>
            <page-range>135-157</page-range>
            <pub-id pub-id-type="pmid">30454739</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23164.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Semler</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Kellum</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Balanced Crystalloid Solutions.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2019</year>
            <month>Apr</month>
            <day>15</day>
            <volume>199</volume>
            <issue>8</issue>
            <fpage>952</fpage>
            <page-range>952-960</page-range>
            <pub-id pub-id-type="pmid">30407838</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23164.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhaskaran</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Arumugam</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Vinay Kumar</surname>
                <given-names>PV</given-names>
              </name>
            </person-group>
            <article-title>A prospective, randomized, comparison study on effect of perioperative use of chloride liberal intravenous fluids versus chloride restricted intravenous fluids on postoperative acute kidney injury in patients undergoing off-pump coronary artery bypass grafting surgeries.</article-title>
            <source>Ann Card Anaesth</source>
            <year>2018</year>
            <season>Oct-Dec</season>
            <volume>21</volume>
            <issue>4</issue>
            <fpage>413</fpage>
            <page-range>413-418</page-range>
            <pub-id pub-id-type="pmid">30333337</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23164.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>P R Brown</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>A Case of Cardiac Arrhythmia from Absorption of Normal Saline during Hysteroscopic Myomectomy.</article-title>
            <source>J Minim Invasive Gynecol</source>
            <year>2019</year>
            <season>May-Jun</season>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>770</fpage>
            <page-range>770-773</page-range>
            <pub-id pub-id-type="pmid">30267897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23164.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>H&#x000f6;jer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Norrh&#x000e4;ll</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Westerbergh</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Play dough ingestion caused pronounced hyperchloremic acidosis in a toddler.</article-title>
            <source>Clin Toxicol (Phila)</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>57</volume>
            <issue>1</issue>
            <fpage>64</fpage>
            <page-range>64-65</page-range>
            <pub-id pub-id-type="pmid">30260241</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23164.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Assimos</surname>
                <given-names>DG</given-names>
              </name>
            </person-group>
            <article-title>Re: Incomplete Distal Renal Tubular Acidosis and Kidney Stones.</article-title>
            <source>J Urol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>201</volume>
            <issue>3</issue>
            <fpage>436</fpage>
            <page-range>436-437</page-range>
            <pub-id pub-id-type="pmid">30759664</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23164.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Finer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Landau</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Clinical Approach to Proximal Renal Tubular Acidosis in Children.</article-title>
            <source>Adv Chronic Kidney Dis</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>351</fpage>
            <page-range>351-357</page-range>
            <pub-id pub-id-type="pmid">30139461</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23164.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Batlle</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Arruda</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Hyperkalemic Forms of Renal Tubular Acidosis: Clinical and Pathophysiological Aspects.</article-title>
            <source>Adv Chronic Kidney Dis</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>321</fpage>
            <page-range>321-333</page-range>
            <pub-id pub-id-type="pmid">30139459</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23164.r13">
          <label>13</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Mustaqeem</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Arif</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <chapter-title>Renal Tubular Acidosis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>17</day>
            <pub-id pub-id-type="pmid">30085586</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23164.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drolz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Horvatits</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Roedl</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rutter</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Brunner</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zauner</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schellongowski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Heinz</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Funk</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Trauner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schneeweiss</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fuhrmann</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Acid-base status and its clinical implications in critically ill patients with cirrhosis, acute-on-chronic liver failure and without liver disease.</article-title>
            <source>Ann Intensive Care</source>
            <year>2018</year>
            <month>Apr</month>
            <day>19</day>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>48</fpage>
            <pub-id pub-id-type="pmid">29675709</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23164.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maheshwari</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Turan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Makarova</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Esa</surname>
                <given-names>WAS</given-names>
              </name>
              <name>
                <surname>Ruetzler</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Barsoum</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kuhel</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Ritchey</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Higuera-Rueda</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kopyeva</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Stocchi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Essber</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Suleiman</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bajracharya</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Chelnick</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mascha</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Kurz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sessler</surname>
                <given-names>DI</given-names>
              </name>
            </person-group>
            <article-title>Saline versus Lactated Ringer's Solution: The Saline or Lactated Ringer's (SOLAR) Trial.</article-title>
            <source>Anesthesiology</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>132</volume>
            <issue>4</issue>
            <fpage>614</fpage>
            <page-range>614-624</page-range>
            <pub-id pub-id-type="pmid">31977517</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23164.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Balanced crystalloids vs 0.9% saline for adult patients undergoing non-renal surgery: A meta-analysis.</article-title>
            <source>Int J Surg</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>51</volume>
            <fpage>1</fpage>
            <page-range>1-9</page-range>
            <pub-id pub-id-type="pmid">29339230</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23164.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Silva</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Ribas Rosa de Oliveira</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Mendes Nogueira</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Vianna</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Amendola</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Carvalho Carmona</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>S&#x000e1; Malbouisson</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Metabolic Acidosis Assessment in High-Risk Surgeries: Prognostic Importance.</article-title>
            <source>Anesth Analg</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>123</volume>
            <issue>5</issue>
            <fpage>1163</fpage>
            <page-range>1163-1171</page-range>
            <pub-id pub-id-type="pmid">27644062</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
